Sentinel lymph node mapping in early-stage breast cancer: Technical issues and results with vital blue dye mapping and radioguided surgery

Journal of Surgical Oncology

Volumn 74, Issue 1, 2000, Pages 61-68

  Canavese, Giuseppe ^a   Gipponi, Marco ^a   Catturich, Alessandra ^a   Di Somma, Carmine ^a   Vecchio, Carlo ^a   Rosato, Francesco ^a   Percivale, Pierluigi ^b   Moresco, Luciano ^b   Nicolò, Guido ^a   Spina, Bruno ^a   Villa, Giuseppe ^b   Bianchi, Pietro ^b   Badellino, Fausto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Axillary lymph node dissection; Breast neoplasms; Lymphatic mapping; Staging

Indexed keywords

DYE;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CONFERENCE PAPER; CONTRAST RADIOGRAPHY; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY;

EID: 0034129492     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200005)74:1<61::AID-JSO14>3.0.CO;2-9     Document Type: Conference Paper

References (35)

1. Burke HB, Hutter RVP, Henson DE. Breast carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, et al, editors. Prognostic factors in cancer. Berlin: Springer; 1995:165-176.
2. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
3. Rosen PP, Lesser ML, Kinne DW, et al. Discontinuous or skip metastases in breast carcinoma. Analysis of 1228 axillary dissection. Ann Surg 1983;97:276-283.
4. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion: an analysis of 539 cases. Cancer 1986;59:682-687.
5. Canavese G, Catturich A, Vecchio C, et al. Linfonodi e livelli ascellari metastatici correlati alla prognosi nel carcinoma mammario. Proceedings of the XVIII Congresso Nazionale Societè Italiana di Chirugia Oncologica. 1994:225-230.
6. Boova R, Bonanni R, Rosato F. Patterns of axillary nodal involvement in breast cancer: predictability of level one dissection. Ann Surg 1982;196:642-644.
7. Pigott J, Nichols R, Maddox W, et al. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984;158:225-229.
8. Steele R, Forrest A, Gibson T, et al. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985;72:368-369.
9. Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990;16:127-133.
10. Canavese G, Catturich A, Vecchio C, et al. Prognostic role of lymph node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998;24:104-109.
11. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
12. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
13. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
14. Graves TA, Bland KI. Surgery for early and minimally invasive breast cancer. Curr Opin Oncol 1996;8:468-477.
15. Hochhauser D. Sparing the lymph nodes but saving the patient. Lancet 1996;348:1723.
16. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
17. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-1780.
18. De Cicco C, Cremonesi M, Chinol M, et al. Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer. Tumori 1997;83:539-541.
19. Hermanek P, Sobin LH, editor. TNM classification of malignant tumors. 5th ed. Berlin: Springer-Verlag; 1997.
20. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-138.
21. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-1544.
22. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-1512.
23. Moss TJ, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-226.
24. Moreno JG, Crose CM, Fisher R, et al. Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res 1992;52:6110-6112.
25. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer 1994;73: 563-569.
26. Maehara Y, Oshiro T, Endo K, et al. Clinical significance of occult micrometastases in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
27. Ross, MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
28. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer 1987; 59:1819-1824.
29. Balch CM, Singletary ES, Bland KI. Clinical decision-making in early breast cancer. Ann Surg 1993;217:207-225.
30. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for Tla breast carcinoma: is it indicated? Cancer 1994;73:664-667.
31. Greco M, Agresti R, Raselli R, et al. Axillary dissection can be avoided in selected breast cancer patients. Analysis of 401 cases. Anticancer Res 1996;16:3913-3918.
32. Senofsky G, Moffat F, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991; 126:1336-1342.
33. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-681.
34. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-130.
35. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996;62:75-77.